Pleural Thickening after Pleural Effusion: How can we Follow-Up in Children?

Tugba Ramasli Gursoy1, Tugba Sismanlar Eyuboglu2, Zeynep Reyhan Onay1

  • 1Department of Pediatric Pulmonology, Gazi University Faculty of Medicine, Ankara, Turkey.

Insights

This study identified factors prolonging pleural thickening resolution after childhood parapneumonic effusion. Older age, fever, and higher effusion amounts were linked to delayed recovery in pediatric patients.

Area of Science:

  • Pediatric Pulmonology
  • Thoracic Medicine
  • Infectious Diseases

Background:

  • Pleural thickening is a common sequela of childhood parapneumonic effusion.
  • Factors influencing the resolution time of pleural thickening remain poorly understood.
  • This study addresses a critical knowledge gap in pediatric thoracic medicine.

Purpose of the Study:

  • To investigate factors affecting the resolution time of pleural thickening following parapneumonic effusion in children.
  • To identify clinical, laboratory, and imaging parameters associated with delayed recovery.
  • To inform clinical management and follow-up strategies for pediatric patients.

Main Methods:

  • Retrospective analysis of 91 pediatric patients diagnosed with pleural thickening post-parapneumonic effusion (2007-2018).
  • Evaluation of patient demographics, clinical presentation, laboratory results, imaging findings (chest X-ray, ultrasonography), and treatment details.
  • Statistical analysis to determine factors influencing pleural thickening resolving time.

Main Results:

  • Pleural thickening resolved in 80% of patients, with a mean resolution time of 151 days.
  • Delayed resolution was associated with older age, prolonged symptoms, pre-admission fever, lower oxygen saturation, crackles on examination, elevated white blood cell count, and higher pleural fluid density.
  • Increased effusion volume, fibrinolytic use, and complications also significantly prolonged resolution time.

Conclusions:

  • Pleural thickening following parapneumonic effusion in children typically resolves within 5 months.
  • Patients with significant effusion, complications, or requiring fibrinolytic therapy need closer monitoring.
  • Routine chest X-ray follow-up may not be necessary for uncomplicated cases.
Abstract

Related Concept Videos

Pleural Effusion I: Introduction01:25

Pleural Effusion I: Introduction

Pleural effusion is an abnormal fluid accumulation in the pleural cavity, a narrow space between the lungs and the chest wall. It is not a disease per se but rather a symptom or indication of an underlying disease. In normal circumstances, this space contains a small amount of fluid (5 to 15 mL), a lubricant facilitating the non-frictional movement of the pleural surfaces.
There are two main types of pleural effusion: transudative and exudative. They are differentiated using Light's...
4.1K
Pleural Effusion II: Symptoms and Management01:28

Pleural Effusion II: Symptoms and Management

Pleural Effusion Overview
A pleural effusion is the abnormal collection of fluid between the parietal and visceral pleura layers of tissue that form the lining of the lungs and chest cavity. It can occur independently or due to surrounding parenchymal diseases, such as infection, malignancy, or inflammatory conditions.
Clinical Manifestations:
695
Pleural Disorders: Types and Brief Description01:30

Pleural Disorders: Types and Brief Description

The pleura is a vital part of the respiratory system. It's a double-layered membrane surrounding the lungs and lining the chest cavity. The two layers of the pleura are:
639
Behavior of Gas Molecules: Molecular Diffusion, Mean Free Path, and Effusion03:48

Behavior of Gas Molecules: Molecular Diffusion, Mean Free Path, and Effusion

Although gaseous molecules travel at tremendous speeds (hundreds of meters per second), they collide with other gaseous molecules and travel in many different directions before reaching the desired target. At room temperature, a gaseous molecule will experience billions of collisions per second. The mean free path is the average distance a molecule travels between collisions. The mean free path increases with decreasing pressure; in general, the mean free path for a gaseous molecule will be...
31.2K
Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
265
Pedigree Analysis01:35

Pedigree Analysis

Overview
89.0K